Nadene Zack joined Daré Bioscience in 2017 and serves as the company’s Vice President of Clinical Operations. She has more than 20 years of experience in clinical drug development and as an independent Clinical Development Consultant, Ms. Zack worked with clinical stage biotech companies in project management, trial development, and trial execution. Ms. Zack has broad therapeutic experience including psychiatry, rheumatology & pain, pulmonology, infectious disease, oncology, and women’s health. Prior to consulting, Ms. Zack held positions of increasing responsibility at Pfizer, Cypress Bioscience, and Aragon Pharmaceuticals leading to NDA submissions and approvals for milnacipran (Savella®) and apalutimide (ERLEADA®) respectively.
Ms. Zack holds a Bachelor of Science Degree in Health Science from San Diego State University and a Master of Science in Clinical Research Administration from George Washington University.